NUCALA (mepolizumab)
MONOCLONAL ANTIBODY, HUMAN INTERLEUKIN 5 ANTAGONIST·HYPEREOSINOPHILIC SYNDROME·+4
GSK
Indication
Eosinophilic chronic obstructive pulmonary disease
Eosinophilic chronic obstructive pulmonary disease is a clinical inflammatory phenotype of chronic obstructive pulmonary disease affecting the respiratory system, typically diagnosed in adults with persistent, incompletely reversible airflow limitation. Read more about Eosinophilic chronic obstructive pulmonary disease
1 drugs 1 manufacturers
Drugs that treat it
Common Eosinophilic chronic obstructive pulmonary disease therapies.
Filter & compare in the drug finder →Opens the drug finder with Eosinophilic chronic obstructive pulmonary disease preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonEosinophilic chronic obstructive pulmonary disease is a clinical inflammatory phenotype of chronic obstructive pulmonary disease affecting the respiratory system, typically diagnosed in adults with persistent, incompletely reversible airflow limitation.
It is defined by heightened type 2 airway inflammation characterized by elevated eosinophil levels in the peripheral blood, sputum, or bronchial tissue rather than the classically predominant neutrophilic response.
Patients with this subtype experience typical chronic respiratory symptoms such as dyspnea, chronic cough, and sputum production, often accompanied by an increased susceptibility to acute exacerbations.
Peripheral blood eosinophil counts serve as a critical biomarker in this population to stratify exacerbation risk and identify patients responsive to targeted anti-inflammatory or biologic therapies.
- nih.gov
Eosinophilic chronic obstructive pulmonary disease is a clinical inflammatory phenotype of chronic obstructive pulmonary disease affecting the respiratory system, typically diagnosed in adults with persistent, incompletely reversible airflow limitation It is defined by heightened type 2 airway inflammation characterized by elevated eosinophil levels in the peripheral blood, sputum, or bronchial tissue rather than the classically predominant neutrophilic response Patients with this subtype experi...
- nih.gov
Eosinophilic chronic obstructive pulmonary disease is a clinical inflammatory phenotype of chronic obstructive pulmonary disease affecting the respiratory system, typically diagnosed in adults with persistent, incompletely reversible airflow limitation Peripheral blood eosinophil counts serve as a critical biomarker in this population to stratify exacerbation risk and identify patients responsive to targeted anti-inflammatory or biologic therapies
- nih.gov
Eosinophilic chronic obstructive pulmonary disease is a clinical inflammatory phenotype of chronic obstructive pulmonary disease affecting the respiratory system, typically diagnosed in adults with persistent, incompletely reversible airflow limitation Patients with this subtype experience typical chronic respiratory symptoms such as dyspnea, chronic cough, and sputum production, often accompanied by an increased susceptibility to acute exacerbations
- nucalahcp.com
It is defined by heightened type 2 airway inflammation characterized by elevated eosinophil levels in the peripheral blood, sputum, or bronchial tissue rather than the classically predominant neutrophilic response Patients with this subtype experience typical chronic respiratory symptoms such as dyspnea, chronic cough, and sputum production, often accompanied by an increased susceptibility to acute exacerbations
- nih.gov
Patients with this subtype experience typical chronic respiratory symptoms such as dyspnea, chronic cough, and sputum production, often accompanied by an increased susceptibility to acute exacerbations
- nih.gov
Peripheral blood eosinophil counts serve as a critical biomarker in this population to stratify exacerbation risk and identify patients responsive to targeted anti-inflammatory or biologic therapies
Personalize your experience
Follow Eosinophilic chronic obstructive pulmonary disease and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.